7月 2026
- 首頁
- Celemics
7月 2026Celemics的市場佔有率分析
Celemics pioneers the dynamic NGS market, utilizing advanced NGS-based sequencing technology to meet the needs of our customers.
Celemics(包含公司地區)
查看更多網站流量與參與度資訊- celemics.com
Celemics截至 7月 2026 的總收入為 2M - 5M
Celemics 熱門網域產生的總收入
Celemics 熱門網域 3 年內的總收入
Celemics 熱門網域的總收入
Celemics的熱門網域總造訪量
了解Celemics市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
Celemics的熱門網域平均造訪時長
分析Celemics參與度指標。
過去 3 個月平均造訪時長
子公司細目
Celemics的熱門網域平均頁面瀏覽量
了解Celemics如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自Celemics
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Amoneta Diagnostics partners with Celemics, Inc..At AD/PD(TM) 2026, Firalis/Amoneta Diagnostics will also present NeuroDeGene(R), a DNA-targeted sequencing panel developed in partnership with Celemics, Inc...
2月 4, 2026閱讀更多
新聞South Dakota State University partnered with Celemics, Inc. on Jul 7th '21.South Dakota State University’s Animal Disease Research and Diagnostic Laboratory (ADRDL) has partnered with Celemics, Inc. to create the first-ever hybridization-based next generation sequencing (NGS) kit to detect viral and bacterial swine respiratory pathogens.
7月 9, 2021閱讀更多
新聞Celemics, Inc. is developing bioinformatics solution.South Korean firm Celemics has announced a partnership with India-based Strand Life Sciences, a leading precision medicine informatics company, to develop a bioinformatics solution capable of providing users with an accelerated means of producing high-quality, in-class clinical genomics reports and enabling a complete sample-to-answer solution, including assay-specific variant filters.
6月 17, 2021閱讀更多
查看所有Celemics信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。
